A Study on the Role of Thrombophilic Genetic Disorders as a Risk Factor for Thrombotic Complications in Patients with Myeloproliferative Disorders

1. Gercheva-Kyuchukova L. [Chronic myeloproliferative neoplasms]. 1st ed. Pleven: Peychinski. 2016. Bulgarian.Search in Google Scholar

2. Lutzkanova E, Marinova I, Pavlova D, Todorov V, Tzvetkov N. [Hematology]. In: Internal diseases part II – medical student book. 1st ed. Pleven: Medical University; 2012, p. 320-34. Bulgarian.Search in Google Scholar

3. Aftab A, Naghmi A, Hassan K. Portal vein thrombosis in a case of chronic myeloid leukemia – a rare association. JIMDC.2013;2(4):87-9.Search in Google Scholar

4. Jain A, Gupta N, Singh T, Agarwal S. A study of haemostatic parameters in patients of chronic myeloid leukaemia. J Clin Diagn Res. 2016;10(7):0C19-0C23.Search in Google Scholar

5. Sora F, Iurlo A, Sica S, Latagliata R, Annunziata M, Galimberti S, et al. Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome. Br J Haematol. 2018;181(2):267-70.10.1111/bjh.1455328169426Search in Google Scholar

6. Lad DP, Jain A, Varma S. Complications and management of coagulation disorders in leukemia patients. Dovepress. 2017;7:61-72.10.2147/BLCTT.S125121646734331360085Search in Google Scholar

7. Elliott MA, Tefferi A. Thrombosis and hemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2004;128(3):275-90.10.1111/j.1365-2141.2004.05277.xSearch in Google Scholar

8. Sykes TC, Fegan C, Mosquera D. Thrombophilia, polymorphisms, and vascular disease. Mol Pathol. 2000;53(6):300-6.10.1136/mp.53.6.300118698411193048Search in Google Scholar

9. Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica. 2002;87(10):1095-108.Search in Google Scholar

10. Foy P, Moll S. Thrombophilia: 2009 update. Curr Treat Options Cardiovasc Med. 2009;11(2):114-28.10.1007/s11936-009-0012-x19289024Search in Google Scholar

11. Kottke-Marchant K. Genetic polymorphisms associated with venous and arterial thrombosis. Arch Pathol Lab Med. 2002;126(3):295-304.10.5858/2002-126-0295-GPAWVA11860303Search in Google Scholar

12. Antonov A, Kovacheva K, Ivanov P, Tsvetkov N, Komsa-Penkova R, Slavcheva V, et al. Genetic thrombophilic defects and risk of thrombotic complications in patients with essential thrombocythemia and polycythemia vera Part II. Contribution of the genetic thrombophilic defects to the thrombotic risk [Internet] [cited 2019 Jun 24]. Available at: https://www.researchgate.net/publication/290579253Search in Google Scholar

13. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-20.10.1111/j.1365-2141.2009.08022.x20128794Search in Google Scholar

14. Maidstone and Tunbridge Wells NHS. Guidelines for thrombophilia testing. [Internet]. [cited 2019 Jun 20]. Available from: https://www.mtw.nhs.uk/wp-content/uploads/2015/09/Guidelines-for-Thrombophilia-Testing1.pdfSearch in Google Scholar

15. Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Michael Streiff, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016;41(1):154-64.10.1007/s11239-015-1316-1471584026780744Search in Google Scholar

16. Voelkerding KV, Wu L, Williams EC, Hoffman SM, Sabatini LM, Borcherding WR, et al. Factor V R506Q gene mutation analysis by PCR-RFLP – optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls. Am J Clin Pathol. 1996;106(1):100-6.10.1093/ajcp/106.1.1008701917Search in Google Scholar

17. Jebeleanu G, Procopciuc L. G20210A prothrombin gene mutation identified in patients with venous leg ulcers. J Cell Mol Med. 2001;5(4):397-401.10.1111/j.1582-4934.2001.tb00174.x674025412067473Search in Google Scholar

18. Potapov EV, Ignatenko S, Nasseri BA, Loebe M, Harke C, Bettmann M, et al. Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support. Ann Thorac Surg. 2004;77(3):869-74.10.1016/j.athoracsur.2003.08.01314992889Search in Google Scholar

19. Samani NJ, Lodwick D. Glycoprotein IIIa polymorphism and risk of myocardial infarction. Cardiovasc Res. 1997;33(3):693-7.10.1016/S0008-6363(96)00222-2Search in Google Scholar

20. Khan S. Dickerman JA. Hereditary thrombophilia. Thromb J. 2006;4(15):1-17.10.1186/1477-9560-4-15Search in Google Scholar

21. Bertina RM. Factor V Leiden and other coagulation risk factor mutations affecting thrombotic risk. Clin Chem. 1997;43(9):1678-83.10.1093/clinchem/43.9.1678Search in Google Scholar

22. Zoeller B, Andreas H, García de Frutos P, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70.Search in Google Scholar

23. Hoerl HD, Tabares A, Kottke-Marchant K. The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature. Vasc Med. 1996. 1(4):275-80.10.1177/1358863X9600100406Search in Google Scholar

24. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346(8983):1133-4.10.1016/S0140-6736(95)91803-5Search in Google Scholar

25. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7.10.1038/369064a08164741Search in Google Scholar

26. Jensen MK, de Nully Brown P, Thorsen S, Hasselbalch HC. Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders. Am J Hematol. 2002;69(3):185-91.10.1002/ajh.1005411891805Search in Google Scholar

27. Trifa AP, Cucuianu A, Popp RA, Coada CA, Costache RM, Militaru MS, et al. Therelationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia. Ann Hematol. 2014;93(2):203-910.1007/s00277-013-1838-623828072Search in Google Scholar

28. Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, et al. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Am J Hematol. 2002;71(1):1-6.10.1002/ajh.1015312221665Search in Google Scholar

29. Afshar-Kharghan V, López JA, Gray LA, Padilla A, Borthakur G, Roberts SC, et al. Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia. Blood Coagul Fibrinolysis. 2004;15(1):21-4.10.1097/00001721-200401000-0000415166939Search in Google Scholar

30. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79(4):706-8.10.1055/s-0037-1615049Search in Google Scholar

31. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF, Férec C, et al. Prevalence of the 20210A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost. 1998;80(1):49-51.10.1055/s-0037-1615137Search in Google Scholar

32. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005, 1-12.10.1182/asheducation.V2005.1.1.1Search in Google Scholar

33. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698-703.10.1182/blood.V88.10.3698.bloodjournal88103698Search in Google Scholar

34. Gisslinger H, Müllner M, Pabinger I, Heis-Vahidi-Fard N, Gisslinger B, Brichta A, et al. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study. Haematologica. 2005;90(3):408-10.Search in Google Scholar

35. Bray PF. Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost. 1999. 82(2):337-44.10.1055/s-0037-1615851Search in Google Scholar

36. Burr D, Doss H, Cooke GE, Goldschmidt-Clermont PJ. A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease. Stat Med. 2003;22(10):1741-60.10.1002/sim.137512720308Search in Google Scholar